Neurotransmisión y neurorreparación
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (4)
2022
-
The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents
ACS Pharmacology and Translational Science, Vol. 5, Núm. 11, pp. 1097-1108
2020
-
Acetylcholinesterase inhibition of diversely functionalized quinolinones for alzheimer’s disease therapy
International Journal of Molecular Sciences, Vol. 21, Núm. 11, pp. 1-20
-
Automated Synthesis of New Quinoxalinetacrines
ChemistrySelect, Vol. 5, Núm. 21, pp. 6491-6493
2019
-
Chromenones as Multineurotargeting Inhibitors of Human Enzymes
ACS Omega, Vol. 4, Núm. 26, pp. 22161-22168